ID

36700

Descrizione

Percutaneous High-dose Radiotherapy in Patients With Oligometastases of Prostate Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT02264379

collegamento

https://clinicaltrials.gov/show/NCT02264379

Keywords

versioni (1)
  1. 03/06/19 03/06/19 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

3 giugno 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Oligometastases NCT02264379

Inglese

Eligibility Oligometastases NCT02264379

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
patient with good general condition (who 0-1)
Descrizione

General health good WHO performance status scale

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1277245
UMLS CUI [1,2]
C1298650
no comorbidities which limit the further life expectancy of the patient to <5 years (opinion of the physician)
Descrizione

Absence Comorbidity Limiting Life Expectancy

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C0009488
UMLS CUI [1,3]
C0439801
UMLS CUI [1,4]
C0023671
histologically confirmed prostate cancer
Descrizione

Prostate carcinoma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0600139
state after definitive local therapy, such as radical prostatectomy or definitive radiotherapy (even after neo-/-adjuvant hormone therapy, after postoperative radiotherapy)
Descrizione

Status post Local Therapy | Radical prostatectomy | Therapeutic radiology procedure | Hormone Therapy Neoadjuvant | Hormone Therapy Adjuvant | Postoperative course of radiotherapy

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0231290
UMLS CUI [1,2]
C1517925
UMLS CUI [2]
C0194810
UMLS CUI [3]
C1522449
UMLS CUI [4,1]
C0279025
UMLS CUI [4,2]
C0600558
UMLS CUI [5,1]
C0279025
UMLS CUI [5,2]
C1522673
UMLS CUI [6]
C0436206
psa relapse after primary therapy or radiological unique metastasis, present complete staging (up to 8 weeks old) by ct thorax/ abdomen/ pelvis and bone scan alternatively a hybrid imaging pet (positron emission tomography) (acetate pet, pet-psma, nafl-pet) and ct / mri is sufficient
Descrizione

PSA Relapse | Status post First line treatment | Neoplasm Metastasis Unique Radiology | Clinical stage finding Complete Chest CT | Clinical stage finding Complete CT of abdomen | Clinical stage finding Complete CT of Pelvis | Clinical stage finding Complete Radioisotope scan of bone | Scanning Systems, Computed Tomography/Positron Emission Tomography | whole body PET with concurrent CT using C-acetate | Positron-Emission Tomography Glutamate Carboxypeptidase II | F-18 Sodium Fluoride Positron Emission Tomography | PET/CT | PET/MRI

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0138741
UMLS CUI [1,2]
C0035020
UMLS CUI [2,1]
C0231290
UMLS CUI [2,2]
C1708063
UMLS CUI [3,1]
C0027627
UMLS CUI [3,2]
C1710548
UMLS CUI [3,3]
C0043299
UMLS CUI [4,1]
C0205563
UMLS CUI [4,2]
C0205197
UMLS CUI [4,3]
C0202823
UMLS CUI [5,1]
C0205563
UMLS CUI [5,2]
C0205197
UMLS CUI [5,3]
C0412620
UMLS CUI [6,1]
C0205563
UMLS CUI [6,2]
C0205197
UMLS CUI [6,3]
C0412628
UMLS CUI [7,1]
C0205563
UMLS CUI [7,2]
C0205197
UMLS CUI [7,3]
C0203668
UMLS CUI [8]
C1139717
UMLS CUI [9]
C4271887
UMLS CUI [10,1]
C0032743
UMLS CUI [10,2]
C0067685
UMLS CUI [11]
C2985493
UMLS CUI [12]
C1699633
UMLS CUI [13]
C3641326
imaging detection of individual metastases (up to 5, depending on the situation) that a radiation therapy are available (histological confirmation of the met is not required)
Descrizione

Neoplasm Metastasis Quantity Imaging | Therapeutic radiology procedure Available

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0011923
UMLS CUI [2,1]
C1522449
UMLS CUI [2,2]
C0470187
no parallel participation to further clinical therapeutic trials to 4 weeks and after radiation
Descrizione

Study Subject Participation Status | Clinical Trials Additional Absent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C0008976
UMLS CUI [2,2]
C1524062
UMLS CUI [2,3]
C0332197
consent of the patient and written informed consent
Descrizione

Informed Consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
severe comorbidity which limit the further life expectancy of the patient to <5 years (opinion of the physician)
Descrizione

Comorbidity Severe | Life Expectancy Limited

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0023671
UMLS CUI [2,2]
C0439801
psa in psa relapse> 10ng/ml
Descrizione

Prostate specific antigen measurement | PSA Relapse

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0201544
UMLS CUI [2,1]
C0138741
UMLS CUI [2,2]
C0035020
ongoing androgen deprivation at the time of study inclusion
Descrizione

Androgen deprivation

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1515985
pre-irradiation in the field of metastases
Descrizione

Therapeutic radiology procedure Field Neoplasm Metastasis

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C1882536
UMLS CUI [1,3]
C0027627
not been carried out local therapy
Descrizione

Local Therapy Absent

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1517925
UMLS CUI [1,2]
C0332197
no histological confirmation of prostate cancer
Descrizione

Confirmation of Prostate carcinoma Absent

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0521091
UMLS CUI [1,2]
C0600139
UMLS CUI [1,3]
C0332197
lack of compliance
Descrizione

Compliance behavior Lacking

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0332268
absence of consent of the patient
Descrizione

Informed Consent Absent

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0332197
Ritorna all'inizio della pagina

Similar models

Eligibility Oligometastases NCT02264379

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
General health good WHO performance status scale
Item
patient with good general condition (who 0-1)
boolean
C1277245 (UMLS CUI [1,1])
C1298650 (UMLS CUI [1,2])
Absence Comorbidity Limiting Life Expectancy
Item
no comorbidities which limit the further life expectancy of the patient to <5 years (opinion of the physician)
boolean
C0332197 (UMLS CUI [1,1])
C0009488 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,3])
C0023671 (UMLS CUI [1,4])
Prostate carcinoma
Item
histologically confirmed prostate cancer
boolean
C0600139 (UMLS CUI [1])
Status post Local Therapy | Radical prostatectomy | Therapeutic radiology procedure | Hormone Therapy Neoadjuvant | Hormone Therapy Adjuvant | Postoperative course of radiotherapy
Item
state after definitive local therapy, such as radical prostatectomy or definitive radiotherapy (even after neo-/-adjuvant hormone therapy, after postoperative radiotherapy)
boolean
C0231290 (UMLS CUI [1,1])
C1517925 (UMLS CUI [1,2])
C0194810 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
C0279025 (UMLS CUI [4,1])
C0600558 (UMLS CUI [4,2])
C0279025 (UMLS CUI [5,1])
C1522673 (UMLS CUI [5,2])
C0436206 (UMLS CUI [6])
PSA Relapse | Status post First line treatment | Neoplasm Metastasis Unique Radiology | Clinical stage finding Complete Chest CT | Clinical stage finding Complete CT of abdomen | Clinical stage finding Complete CT of Pelvis | Clinical stage finding Complete Radioisotope scan of bone | Scanning Systems, Computed Tomography/Positron Emission Tomography | whole body PET with concurrent CT using C-acetate | Positron-Emission Tomography Glutamate Carboxypeptidase II | F-18 Sodium Fluoride Positron Emission Tomography | PET/CT | PET/MRI
Item
psa relapse after primary therapy or radiological unique metastasis, present complete staging (up to 8 weeks old) by ct thorax/ abdomen/ pelvis and bone scan alternatively a hybrid imaging pet (positron emission tomography) (acetate pet, pet-psma, nafl-pet) and ct / mri is sufficient
boolean
C0138741 (UMLS CUI [1,1])
C0035020 (UMLS CUI [1,2])
C0231290 (UMLS CUI [2,1])
C1708063 (UMLS CUI [2,2])
C0027627 (UMLS CUI [3,1])
C1710548 (UMLS CUI [3,2])
C0043299 (UMLS CUI [3,3])
C0205563 (UMLS CUI [4,1])
C0205197 (UMLS CUI [4,2])
C0202823 (UMLS CUI [4,3])
C0205563 (UMLS CUI [5,1])
C0205197 (UMLS CUI [5,2])
C0412620 (UMLS CUI [5,3])
C0205563 (UMLS CUI [6,1])
C0205197 (UMLS CUI [6,2])
C0412628 (UMLS CUI [6,3])
C0205563 (UMLS CUI [7,1])
C0205197 (UMLS CUI [7,2])
C0203668 (UMLS CUI [7,3])
C1139717 (UMLS CUI [8])
C4271887 (UMLS CUI [9])
C0032743 (UMLS CUI [10,1])
C0067685 (UMLS CUI [10,2])
C2985493 (UMLS CUI [11])
C1699633 (UMLS CUI [12])
C3641326 (UMLS CUI [13])
Neoplasm Metastasis Quantity Imaging | Therapeutic radiology procedure Available
Item
imaging detection of individual metastases (up to 5, depending on the situation) that a radiation therapy are available (histological confirmation of the met is not required)
boolean
C0027627 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0011923 (UMLS CUI [1,3])
C1522449 (UMLS CUI [2,1])
C0470187 (UMLS CUI [2,2])
Study Subject Participation Status | Clinical Trials Additional Absent
Item
no parallel participation to further clinical therapeutic trials to 4 weeks and after radiation
boolean
C2348568 (UMLS CUI [1])
C0008976 (UMLS CUI [2,1])
C1524062 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
Informed Consent
Item
consent of the patient and written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Comorbidity Severe | Life Expectancy Limited
Item
severe comorbidity which limit the further life expectancy of the patient to <5 years (opinion of the physician)
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0023671 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
Prostate specific antigen measurement | PSA Relapse
Item
psa in psa relapse> 10ng/ml
boolean
C0201544 (UMLS CUI [1])
C0138741 (UMLS CUI [2,1])
C0035020 (UMLS CUI [2,2])
Androgen deprivation
Item
ongoing androgen deprivation at the time of study inclusion
boolean
C1515985 (UMLS CUI [1])
Therapeutic radiology procedure Field Neoplasm Metastasis
Item
pre-irradiation in the field of metastases
boolean
C1522449 (UMLS CUI [1,1])
C1882536 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
Local Therapy Absent
Item
not been carried out local therapy
boolean
C1517925 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Confirmation of Prostate carcinoma Absent
Item
no histological confirmation of prostate cancer
boolean
C0521091 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Compliance behavior Lacking
Item
lack of compliance
boolean
C1321605 (UMLS CUI [1,1])
C0332268 (UMLS CUI [1,2])
Informed Consent Absent
Item
absence of consent of the patient
boolean
C0021430 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial